Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.15USD
1:33pm EST
Change (% chg)

$-0.22 (-16.06%)
Prev Close
$1.37
Open
$1.37
Day's High
$1.37
Day's Low
$1.15
Volume
9,038
Avg. Vol
69,009
52-wk High
$17.22
52-wk Low
$1.12

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -1.53 -- --
ROI: -95.74 9.00 14.96
ROE: -149.70 10.14 16.53

Earnings vs. Estimates